Healthcare - Biotechnology - NASDAQ - US
$ 6.17
-5.8 %
$ 524 M
Market Cap
-4.67
P/E
INCOME STATEMENT
0
REVENUE
-103 M
OPERATING INCOME
-90.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Terns Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 881 K |
| Gross Profit | -881 K |
| Operating Expenses | 103 M |
| Operating Income | -103 M |
| Other Expenses | -12.3 M |
| Net Income | -90.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 1.0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.9 | 1.0 | 0.5 | 0.4 | 0.2 | 65 K |
| Gross Profit | (0.9) | (1.0) | 0.5 | (0.4) | (0.2) | 65 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 102.6 | 62.0 | 50.9 | 37.0 | 70.2 | 18.5 |
| Selling, General and Administrative Expenses | 39.1 | 22.4 | 19.5 | 9.0 | 8.7 | 3.9 |
| Research and Development Expenses | 63.5 | 39.6 | 31.3 | 28.0 | 61.5 | 14.6 |
| Operating Income | (102.6) | (62.0) | (49.9) | (37.0) | (70.2) | (18.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (2.0) | 0 | 0 | 0 | 0 |
| Total Other Income | 12.6 | 2.0 | 0.2 | (2.7) | 1.4 | 0.4 |
| Pre-Tax Income | (90.0) | (60.0) | (49.6) | (39.8) | (68.8) | (18.1) |
| NET INCOME | ||||||
| Tax Provision | 0.2 | 0.4 | 0.5 | 0.8 | 20 K | 67 K |
| Net Income | (90.2) | (60.3) | (50.2) | (40.6) | (68.8) | (17.7) |
| EPS | 1.27 | 1.67 | 1.98 | 1.61 | 2.74 | 0.74 |